LCBVX
Price
$44.55
Change
-$0.38 (-0.85%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

LCBVX vs RMFCX

Header iconLCBVX vs RMFCX Comparison
Open Charts LCBVX vs RMFCXBanner chart's image
ClearBridge Large Cap Value R
Price$44.55
Change-$0.38 (-0.85%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
LCBVX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LCBVX vs. RMFCX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCBVX is a StrongSell and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. LCBVX (2.51B). RMFCX pays higher dividends than LCBVX: RMFCX (1.69) vs LCBVX (0.65). LCBVX was incepted earlier than RMFCX: LCBVX (11 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. LCBVX (18.00). LCBVX has a lower initial minimum investment than RMFCX: LCBVX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. LCBVX (9.64). RMFCX return over 5 years is better than : 40.39 vs. LCBVX (36.48).
LCBVXRMFCXLCBVX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD9.97511.42387%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.51B104B2%
Annual Yield % from dividends0.651.6938%
Returns for 1 year9.6412.6376%
Returns for 3 years12.5614.1689%
Returns for 5 years36.4840.3990%
Returns for 10 years61.4361.8499%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc